02/12/2025
12:05 PM | Cadrenal Therapeutics (Subject)
Havlickova 648 a.s. (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
3:09 PM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
3:50 PM | Cadrenal Therapeutics (Issuer)
Ferguson James J. III (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
3:51 PM | Cadrenal Therapeutics (Issuer)
Ferguson James J. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:12 PM | Cadrenal Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/29/2025
6:29 PM | Cadrenal Therapeutics (Subject)
Pham Quang X (Filed by)
| Form SCHEDULE 13D | |
01/24/2025
5:09 PM | Cadrenal Therapeutics (Issuer)
Lisicki Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
5:10 PM | Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
5:10 PM | Cadrenal Therapeutics (Issuer)
Szot Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
5:11 PM | Cadrenal Therapeutics (Issuer)
Cole Jeffrey Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
5:12 PM | Cadrenal Therapeutics (Issuer)
Zelenkofske Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CVKD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/24/2025
5:13 PM | Cadrenal Therapeutics (Issuer)
WILSON GLYNN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
5:13 PM | Cadrenal Therapeutics (Issuer)
MURPHY JOHN RAYMOND (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:23 PM | Cadrenal Therapeutics (Subject)
MURPHY JOHN RAYMOND (Filed by)
| Form SCHEDULE 13G/A | |
12/23/2024
3:44 PM | Cadrenal Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/20/2024
4:28 PM | Cadrenal Therapeutics (Filer)
| Form 424B5 | |
11/25/2024
3:53 PM | Cadrenal Therapeutics (Filer)
| Form 424B3 | |
11/24/2024
11:15 PM | Cadrenal Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
8:00 AM | Cadrenal Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/07/2024
8:10 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:41 PM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
8:13 AM | Cadrenal Therapeutics (Filer)
| Form 424B5 | |
10/24/2024
8:10 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:15 PM | Cadrenal Therapeutics (Subject)
Havlickova 648 a.s. (Filed by)
| Form SC 13G | |
09/25/2024
3:05 PM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
5:03 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
5:03 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:02 PM | Cadrenal Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:05 PM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
4:25 PM | Cadrenal Therapeutics (Filer)
| Form DEF 14A | |
06/11/2024
4:27 PM | Cadrenal Therapeutics (Filer)
| Form ARS | |
05/29/2024
4:27 PM | Cadrenal Therapeutics (Filer)
| Form PRE 14A | |
05/09/2024
5:23 AM | Cadrenal Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/10/2024
4:30 PM | Cadrenal Therapeutics (Issuer)
Pham Quang X (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
8:26 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
11:15 PM | Cadrenal Therapeutics (Filer)
| Form EFFECT | |
03/20/2024
11:15 PM | Cadrenal Therapeutics (Filer)
| Form EFFECT | |
03/12/2024
7:37 AM | Cadrenal Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
7:04 AM | Cadrenal Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/11/2024
8:15 AM | Cadrenal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
